Clinical data indicate that autologous dendritic cell vaccines combined with IL-2 decreased TGF-β and CD4+CD25+ T cell levels and increased IL-12p70 levels in renal cell carcinoma or breast cancer patients. Here, IL2 is linked to renal cell carcinoma.